C. Montiel et al., SEROTONERGIC EFFECTS OF DOTARIZINE IN CORONARY-ARTERY AND IN OOCYTES EXPRESSING 5-HT2 RECEPTORS, European journal of pharmacology, 332(2), 1997, pp. 183-193
In strips of pig coronary arteries incubated in oxygenated Krebs-bicar
bonate solution at 37 degrees C, dotarizine blocked the phasic contrac
tions evoked by 5-HT (0.5 mu M) or K+ depolarization (35 mM K+) with a
n IC50 of 0.22 and 3.7 mu M, respectively. Flunarizine inhibited both
types of contractions with IC50 values of 1.7 mu M for 5-HT and 2.4 nM
for K+ responses. In Xenopus oocytes injected with in vitro transcrib
ed RNA encoding for 5-HT2A or 5-HT2C receptors, 5-HT (100 nM for 20 s)
applied every IO min caused, in both cases, a reproducible inward cur
rent through Ca2+-activated Cl- channels (I-Cl). Dotarizine inhibited
the 5-HT2A response in a concentration-dependent manner, with an IC50
of 2.2 nM. In contrast, the 5-HT2C response was unaffected by 1 mu M d
otarizine and blocked around 62% by 10 mu M Of this drug. The l(Cl) ac
tivated either by intracellular injection of inositol 1,4,5-trisphosph
ate (IP3) in oocytes or by direct photorelease of Ca2+ in DM-nitrophen
-injected oocytes was unaffected by 10 mu M dotarizine. It is conclude
d that dotarizine blocks 5-HT2A receptors with a high affinity; the co
mpound is devoid of intracellular effects on any further steps of the
transduction pathway (i.e., IP3 receptor). Contrary to flunarizine tha
t blocks equally well the serotonergic and the K+ vascular responses,
dotarizine exhibits 17-fold higher affinity for vascular 5-HT receptor
s. These findings might be relevant to an understanding of the mechani
sm involved in the use of dotarizine and flunarizine as prophylactic a
gents in migraine. (C) 1997 Elsevier Science B.V.